Skip to main content

Detail

Noemi Kiss
Noemi Kiss, MSc.

Center for Public Health (Department of Health Economics)
Position: Research Assistant

T +43 1 40160 34845
noemi.kiss@meduniwien.ac.at

Further Information

Keywords

Aging; Economic Competition; Economic Development; Economics, Hospital; Economics, Medical; Economics, Pharmaceutical; Health Care Costs; Health Care Economics and Organizations; Health Care Evaluation Mechanisms; Health Care Reform; Health Care Surveys; Health economics; Home Care Services; Models, Economic; Nursing Homes; Nutrition Surveys; Nutrition Therapy; Oncology; Outcome Assessment (Health Care); Physical and Rehabilitation Medicine

Research group(s)

  • Health Economics
  • nutritionDay

Research interests

Broad Interests:

  • Comparative health system economics and policy making
  • Economic evaluations for decision making and the development of health technology assessment institutions
  • Pricing and reimbursement of pharmaceuticals, devices, and services
  • Multi-sectoral and/or multi-payer interventions and services

Specific Interests:

  • Reablement, physiotherapy, rehabilitation, social services for elderly after a fall, medical event, or life event
  • The economics of hospital nutrition, ICU nutrition, nutrition in nursing homes, and nutrition in oncology
  • Physical therapy
  • Chronic back pain
  • Health care services in the home
  • Disinvestment mechanisms for hospitals and health care systems
  • Cost-effectiveness and cost-utility analysis
  • Ocular disease outcomes and cost-effectiveness
  • Weight loss outcomes and cost-effectiveness in obese individuals

Techniques, methods & infrastructure

Skills:

  • Systematic reviews
  • Targeted reviews
  • Cost-effectiveness analysis
  • Cost-utility analysis
  • Statistical analysis (using Stata, R)
  • Multinational surveys
  • Native English speaker
  • Cost of illness studies

Selected publications

  1. Schneider, J.E. et al., 2011. Tobacco litter costs and public policy: a framework and methodology for considering the use of fees to offset abatement costs. Tobacco Control, 20(Supplement 1), pp.i36-i41. Available at: http://dx.doi.org/10.1136/tc.2010.041707.
  2. Schneider, J.E. et al., 2012. Economics of cancer biomarkers. Personalized Medicine, 9(8), pp.829-837. Available at: http://dx.doi.org/10.2217/pme.12.87.
  3. Khan, N., Kiss, N. & Pang, F., 2011. NI3 Economic Evaluation in Niche Markets: The Role of the UK's Advisory Group for National Specialised Services for Rare Diseases and Disorders. Value in Health, 14(7), p.A238. Available at: http://dx.doi.org/10.1016/j.jval.2011.08.036.
  4. Kiss, N. et al., 2012. PCN108 Quality of Life and Patient Preferences in Platinum Sensitive Ovarian Cancer. Value in Health, 15(7), p.A429. Available at: http://dx.doi.org/10.1016/j.jval.2012.08.2148.
  5. Kiss, N., Sidhu, M. & Tongbram, V., 2012. PRM42 Managing a Systematic Literature Review Project. Value in Health, 15(7), p.A467. Available at: http://dx.doi.org/10.1016/j.jval.2012.08.1506.